Literature DB >> 6790295

Thyrotropin-releasing hormone and amphetamine produce different patterns of behavioral excitation in rats.

G N Ervin, S A Schmitz, C B Nemeroff, A J Prange.   

Abstract

We compared the arousal and hyperactivity produced by intraperitoneal (i.p.) injections of thyrotropin-releasing hormone (TRH, pGlu-His-Pri-NH2; 10, 20, 30 and 60 mg/kg) and 0.3 and 2 mg/kg d-amphetamine (low and moderate amph., respectively) by measuring the occurrence of discrete behavioral items with a behavioral sampling and scoring method. To minimize extraneous variables affecting activity, rats were caged singly inside isolated observation chambers and tested in the daytime after a 2.5 h period of habituation. Under these conditions, vehicle (0.9% NaCl)-treated rats were inactive and either rested or slept through 80% of all time samples taken in the hour after injection. Both TRH and amph. produced significant arousal from sleeping, but TRH, at all doses tested, produced less arousal than moderate amph. and a pattern of behavioral responses which differed from both low and moderate amph. Moderate amph. produced marked increase in forward locomotion and rearing, but low amph. and TRH did not. Both TRH and low amph. increased grooming (perhaps simply by increasing wakefulness), but TRH failed to increase sniffing, a cardinal feature of ampha.-induced excitement. Unlike amph., TRH produced wet-dog shakes, piloerection, tail elevation and teeth chattering. Both mod. amph. and TRH significantly produced increased activity when compared to controls as assessed with photocell counts, though the amph. effect was more robust. The lack of arousal after i.p. injections of thyroid-stimulating hormone (10 I.U./kg) or melanocyte-stimulating hormone release-inhibiting factor (Pro-Leu-Gly-NH2; 60 mg/kg) is evidence that TRH-induced arousal is neither mediated by activation of the pituitary-thyroid axis nor by a non-specific effect of tripeptides generally.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6790295     DOI: 10.1016/0014-2999(81)90294-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Odor detection performance of rats following d-amphetamine treatment: a signal detection analysis.

Authors:  R L Doty; M Ferguson-Segall
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Thyrotropin-releasing hormone (TRH) inhibits melanin-concentrating hormone neurons: implications for TRH-mediated anorexic and arousal actions.

Authors:  Xiaobing Zhang; Anthony N van den Pol
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

3.  Involvement of both opiate and catecholaminergic receptors of ventromedial hypothalamus in the locomotor stimulant action of thyrotropin-releasing hormone.

Authors:  L S Lin; W T Chiu; C J Shih; M T Lin
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

4.  Acute and long-term effects of thyrotropin releasing hormone on behavior mediated by dopaminergic and cholinergic activities in mice.

Authors:  I Ushijima; K Yamada; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  The effects of amphetamine injections on feeding behavior and the brain expression of orexin, CART, tyrosine hydroxylase (TH) and thyrotropin releasing hormone (TRH) in goldfish (Carassius auratus).

Authors:  Hélène Volkoff
Journal:  Fish Physiol Biochem       Date:  2012-12-11       Impact factor: 2.794

6.  Thyrotropin-releasing hormone increases behavioral arousal through modulation of hypocretin/orexin neurons.

Authors:  Junko Hara; Dmitry Gerashchenko; Jonathan P Wisor; Takeshi Sakurai; Xinmin Xie; Thomas S Kilduff
Journal:  J Neurosci       Date:  2009-03-25       Impact factor: 6.167

7.  Imaging the neural circuitry and chemical control of aggressive motivation.

Authors:  Craig F Ferris; Tara Stolberg; Praveen Kulkarni; Murali Murugavel; Robert Blanchard; D Caroline Blanchard; Marcelo Febo; Mathew Brevard; Neal G Simon
Journal:  BMC Neurosci       Date:  2008-11-13       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.